NeRRe Therapeutics is a clinical stage company progressing a unique portfolio of three neurokinin-1 antagonists (NK-1RAs) for the treatment of common, chronic and debilitating conditions, caused by neuronal hypersensitivity related to NK-1 receptor system dysfunction.
NeRRe Therapeutics Ltd.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.nerretherapeutics.com
Founded2012
Disease Focus
Development StageClinical
STOCK CODENon Listed
AddressStevenage Bioscience CatalystIncubator BuildingGunnels Wood Road, Stevenage HERTSSG1 2FXHertfordshireUnited Kingdom
Stevenage Bioscience CatalystIncubator BuildingGunnels Wood Road, Stevenage HERTSSG1 2FX
Hertfordshire
United Kingdom
Contact Number+44 1438 906 960
+44 1438 906 960
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/nerre-therapeutics-ltd” connections=”true” suffix=””]